Day: March 6, 2024

Fourth Quarter 2023 Total Revenues of $277 million, which aligned our Full Year to the mid-point of guidance Full Year 2023 Total Revenues of $1.05 billion, which was the mid-point of guidance Fourth Quarter 2023 Net Loss of $50 million and Adjusted EBITDA of $3 million Issues Q1 2024 and FY 2024 guidanceGAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2023. “Emergent has a long history of helping protect people around the world from opioid overdose emergencies and chemical, biological and radiological threats. This commitment to public health, together with Emergent’s leadership, give me confidence in the long-term future of the company,” said Joe Papa, President and CEO at Emergent. “Emergent...

Dallas, Texas, March 06, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $7.6 million, or $.16 per share, in the fourth quarter of 2023 compared to a net loss attributable to NL stockholders of $6.1 million, or $.13 per share, in the fourth quarter of 2022. NL’s results include an unrealized gain of $2.4 million in the fourth quarter of 2023 related to the change in value of marketable equity securities compared to a $3.8 million unrealized loss in the fourth quarter of 2022. For the full year of 2023, NL reported a net loss attributable to NL stockholders of $2.3 million, or $.05 per share, compared to net income attributable to NL stockholders of $33.8 million, or $.69 per share for the full year of 2022. NL’s results include an unrealized loss of $8.1 million...

– Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia – Development of breakthrough immune-quiet DNA for hemophilia A program continues – Cash balance of $264.4 million expected to fund operations into 2H 2027 CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and fourth quarter and full year 2023 financial results. “Late last year we announced important advances in our cell-targeted lipid nanoparticle and immune-quiet DNA platforms that we are now translating to our portfolio strategy,” said Geoff McDonough, M.D., chief executive officer...

Fourth quarter adjusted operating income and adjusted diluted EPS at the high-end of guidance Generated nearly $590 million in operating cash flow in the fourth quarter and ended the year with debt down over $150 million year-over-year Announces new $250 million share repurchase authorization Provides initial full year and first quarter 2024 guidance REYNOLDSBURG, Ohio, March 06, 2024 (GLOBE NEWSWIRE) — Victoria’s Secret & Co. (“Victoria’s Secret” or the “Company”) (NYSE: VSCO) today reported 2023 financial results for the fourth quarter and fiscal year ended February 3, 2024. Chief Executive Officer Martin Waters commented on the fourth quarter, “I am grateful for the hard work and dedication of our team of associates and partners around the world who executed our strategies, delighted our customers and delivered solid financial...

Dallas, Texas, March 06, 2024 (GLOBE NEWSWIRE) — Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $5.3 million, or $.05 per share, in the fourth quarter of 2023 compared to a net loss of $19.9 million, or $.18 per share, in the fourth quarter of 2022. For the full year of 2023, Kronos Worldwide reported a net loss of $49.1 million, or $.43 per share, compared to net income of $104.5 million, or $.90 per share for the full year of 2022. Net income increased in the fourth quarter of 2023 as compared to the fourth quarter of 2022 primarily due to higher income from operations as a result of the net effect of higher sales volumes, lower average TiO2 selling prices and lower production costs (primarily raw material costs). Net income decreased in the full year of 2023 as compared to the full year 2022 primarily due to...

    OMEGA FLEX, INC. (OFLX)    For the Period Ended December 31,    Twelve Months   Three Months                       2023     2022     2023     2022                 Net Sales   $111,465,000   $125,487,000   $28,147,000   $30,817,000                                  Net Income attributable to Omega Flex, Inc.   $20,763,000   $23,622,000   $4,889,000   $6,181,000                                  Earnings Per Share – Basic and Diluted   $2.06   $2.34   $0.48   $0.61                                  Weighted Average Shares – Basic and Diluted     10,094,322     10,094,322     10,094,322     10,094,322                 EXTON, Pa., March 06, 2024 (GLOBE NEWSWIRE) — Dean W. Rivest, CEO, announced that net sales of Omega Flex, Inc. (the “Company” or “Omega Flex”) for 2023 and 2022...

– Full Year 2023 Revenues and Share of NPI Revenues Interest total $254.6 million –– Full Year 2023 Net Loss of $18.3 million and Adjusted Net Income, after taking effect of the amortization of Aspire intangibles, was $12.8 million –– Full Year 2023 Adjusted EBITDA total $76.2 million, an increase of 39.8% year-over-year –– Expected Timeline for Completion of the Aristocrat Business Combination during the second quarter 2024 – LUXEMBOURG, March 06, 2024 (GLOBE NEWSWIRE) — NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery and iGaming solutions, announced today financial results for the fourth quarter and year ended December 31, 2023. Moti Malul, Chief Executive Officer of NeoGames, said: “We are very pleased with the progress we made during the fourth quarter and during...

– Fourth Quarter Revenue of $194 Million, up 17% Year-over-Year –– Full Year 2023 Revenue of $691 Million, up 17% –– Fourth Quarter and Full Year Net Loss of $5.5 Million and $60.1 Million, respectively –– Fourth Quarter and Full Year Adjusted EBITDA of $11.5 Million and $8.2 Million, respectively –– Strong Fourth Quarter 2023 Momentum Reflected in Full Year 2024 Revenue Guidance of Between $770 and $830 Million –– Initiating Full Year 2024 Adjusted EBITDA Guidance of Between $35 and $45 Million – CHICAGO, March 06, 2024 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced financial results for the fourth quarter and full year...